Sign inGet started

Halawa Alaa

Insider CIK 1992622 · NMRA Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
NMRA Neumora Therapeutics, Inc. A Award deriv2026-05-272026-05-2980,000— $080,000SEC↗
NMRA Neumora Therapeutics, Inc. A Award deriv2025-05-282025-05-3080,000— $080,000SEC↗
NMRA Neumora Therapeutics, Inc. D To issuer deriv2025-05-282025-05-3046,455— $00SEC↗
NMRA Neumora Therapeutics, Inc. D To issuer deriv2025-05-282025-05-3028,571— $00SEC↗
NMRA Neumora Therapeutics, Inc. A Award deriv2025-05-282025-05-3046,455— $046,455SEC↗
NMRA Neumora Therapeutics, Inc. A Award deriv2025-05-282025-05-3028,571— $028,571SEC↗
NMRA Neumora Therapeutics, Inc. D To issuer deriv2025-02-132025-02-1846,455— $00SEC↗
NMRA Neumora Therapeutics, Inc. A Award deriv2025-02-132025-02-1828,571— $028,571SEC↗
NMRA Neumora Therapeutics, Inc. A Award deriv2025-02-132025-02-1846,455— $046,455SEC↗
NMRA Neumora Therapeutics, Inc. D To issuer deriv2025-02-132025-02-1828,571— $00SEC↗
NMRA Neumora Therapeutics, Inc. A Award deriv2024-06-132024-06-1428,571— $028,571SEC↗
NMRA Neumora Therapeutics, Inc. A Award2024-06-132024-06-1420,100— $020,100SEC↗
NMRA Neumora Therapeutics, Inc. A Award deriv2023-09-142023-09-1846,455— $046,455SEC↗